Literature DB >> 915000

Parathyroidectomy reduces 25-hydroxyvitamin D3-1 alpha-hydroxylase activity in the hypocalcemic vitamin D-deficient chick.

B E Booth, H C Tsai, R C Morris.   

Abstract

To test the hypothesis that in the vitamin D-deficient state the activity of 25-hydroxyvitamin D3-1 alpha-hydroxylase (25-OHD3-1 alpha-hydroxylase) is modulated by parathyroid hormone and the plasma concentration of phosphate only in the presence of small amounts of 1,25-dihydroxyvitamin D3 (or some other metabolite of vitamin D), we measured the activity of this enzyme 24 h after parathyroidectomy (PTX) in frankly hypocalcemic, vitamin D-deficient chicks that were not supplemented with vitamin D or one of its metabolites. The otherwise predictable complications of PTX in this metabolic setting (hypocalcemia of increasing severity, tetany, moribundity, and death) were prevented by continuous intravenous administration of calcium (as a solution of calcium chloride/calcium gluconate 1:1) through a catheter in the external jugular vein placed at the time of PTX. The findings were as follows: (a) The activity of 25-OHD3-1 alpha-hydroxylase was significantly less in the parathyroidectomized group than in the sham-operated control chicks (P less than 0.001). (b) The reductive effect of PTX on the activity of this enzyme was significantly attenuated when hypophosphatemia was increased in severity by administration of glucose. (c) In the post-PTX state the activity of 25-OHD3-1 alpha-hydroxylase and plasma concentration of phosphate were significantly, inversely related (P less than 0.001). (d) In the sham-operated control group the activity of this enzyme and the plasma concentration of phosphate were not significantly correlated. These findings indicate that in the vitamin D-deficient state, both circulating parathyroid hormone and the plasma concentration of phosphate can significantly modulate the activity of 25-OHD3-1 alpha-hydroxylase in the absence of vitamin D or its metabolites. The findings also suggest that in the vitamin D-deficient state the plasma concentration of phosphate modulates the activity of this enzyme only when the concentration of circulating parathyroid hormone is not increased.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915000      PMCID: PMC372487          DOI: 10.1172/JCI108890

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  A new chromatographic system for vitamin D3 and its metabolites: resoluation of a new vitamin D3 metabolite.

Authors:  M F Holick; H F DeLuca
Journal:  J Lipid Res       Date:  1971-07       Impact factor: 5.922

2.  Studies on calciferol metabolism. VII. The renal production of the biologically active form of vitamin D, 1,25-dihydroxycholecalciferol; species, tissue and subcellular distribution.

Authors:  R J Midgett; A M Spielvogel; J W Coburn; A W Norman
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

3.  Biological activity of the vitamin D metabolite 1,25-dihydroxycholecalciferol in chickens and rats.

Authors:  A W Norman; R G Wong
Journal:  J Nutr       Date:  1972-12       Impact factor: 4.798

4.  Control of 25-hydroxycholecalciferol metabolism by parathyroid glands.

Authors:  M Garabedian; M F Holick; H F Deluca; I T Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

5.  Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol.

Authors:  H Rasmussen; M Wong; D Bikle; D B Goodman
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

6.  Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney.

Authors:  M F Holick; H K Schnoes; H F DeLuca; R W Gray; I T Boyle; T Suda
Journal:  Biochemistry       Date:  1972-11-07       Impact factor: 3.162

7.  1,25-dihydroxycholecalciferol: metabolite of vitamin D3 active on bone in anephric rats.

Authors:  M F Holick; M Garabedian; H F DeLuca
Journal:  Science       Date:  1972-06-09       Impact factor: 47.728

8.  The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats.

Authors:  I T Boyle; L Miravet; R W Gray; M F Holick; H F Deluca
Journal:  Endocrinology       Date:  1972-03       Impact factor: 4.736

9.  The metabolism of vitamin D 3 in the chick.

Authors:  M R Haussler; H Rasmussen
Journal:  J Biol Chem       Date:  1972-04-25       Impact factor: 5.157

10.  Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol.

Authors:  I T Boyle; R W Gray; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

View more
  8 in total

1.  The human response to acute enteral and parenteral phosphate loads.

Authors:  Roberto Scanni; Matthias vonRotz; Sigrid Jehle; Henry N Hulter; Reto Krapf
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

2.  Influence of pregnancy on immunoreactive parathyroid hormone levels.

Authors:  M E Gillette; K L Insogna; A M Lewis; D T Baran
Journal:  Calcif Tissue Int       Date:  1982-01       Impact factor: 4.333

3.  Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men.

Authors:  A A Portale; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

4.  Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D.

Authors:  A A Portale; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

5.  Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

Authors:  A A Portale; B E Booth; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

6.  Vitamin D metabolism: new concepts and clinical implications.

Authors:  P H Anderson; B K May; H A Morris
Journal:  Clin Biochem Rev       Date:  2003

7.  Vitamin D status regulates 25-hydroxyvitamin D3-1 alpha-hydroxylase and its responsiveness to parathyroid hormone in the chick.

Authors:  B E Booth; H C Tsai; R C Morris
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

8.  Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans.

Authors:  A A Portale; B P Halloran; M M Murphy; R C Morris
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.